Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

I.R.C.C.S. Fondazione Santa Lucia clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Italy register with I.R.C.C.S. Fondazione Santa Lucia as lead sponsor. Synced 16 Nov 2026
15Current trials
9Recruiting now
0Drugs in these trials
1Trial register
At a glance

I.R.C.C.S. Fondazione Santa Lucia is the lead sponsor of 15 current clinical trials in our Italy register. 9 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Stroke.

ClinicalTrials.gov trials by status

  • Recruiting960%
  • Active, closed640%

Trials by phase

  • Not applicable1067%
  • Phase 4320%
  • Phase 317%
  • Observational17%
01

Clinical trials sponsored by I.R.C.C.S. Fondazione Santa Lucia

15 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Using Glialia for Treating Persistent Perceptual Postural Dizziness
NCT06741358 · ClinicalTrials.gov ↗ · Persistent Postural Perceptual Dizziness
Phase 4 Recruiting 2024-12 Italy
A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease
NCT06702124 · ClinicalTrials.gov ↗ · Alzheimer Disease
Phase 3 Recruiting 2023-12 Italy
Novel Personalized Non Invasive Combined Magnetic and Electrical Stimulation of the DMN in Mild AD Patients
NCT07075770 · ClinicalTrials.gov ↗ · Alzheimer Disease
Not applicable Recruiting 2025-01 Italy
Spatiotemporal Entrainment Neuromodulation Targeting Cerebello-Cerebral Circuits to Enhance Cognitive and Social Rehabilitation in Cerebellar Diseases
NCT07500103 · ClinicalTrials.gov ↗ · Cerebellar Degeneration, Cerebellar Malformation
Not applicable Recruiting 2025-01 Italy
Visuo-Vestibular VR-based Stimulation Effects on Balance and Gait in Stroke Survivors
NCT06780488 · ClinicalTrials.gov ↗ · Stroke
Not applicable Recruiting 2025-01 Italy
Fundus Camera Module for Early Detection of Alzheimer's Disease
NCT06841848 · ClinicalTrials.gov ↗ · Alzheimer Disease
Observational Recruiting 2023-05 Italy
EMG Control Assistance Virtual Reality Interface Coupled With Cerebellar-iTBS for Arm Recovery After Stroke (ERICA)
NCT06911671 · ClinicalTrials.gov ↗ · Stroke, Stroke, Cardiovascular
Not applicable Recruiting 2025-04 Italy
Gentle Touch for Post-Mastectomy Lymphedema
NCT07257679 · ClinicalTrials.gov ↗ · Lymphedema, Breast Cancer
Phase 4 Recruiting 2025-11 Italy
Effects of Cerebellar tACS-iTBS in Ataxia
NCT06420271 · ClinicalTrials.gov ↗ · Ataxia
Not applicable Recruiting 2025-05 Italy
Virtual Reality Therapy for Arm Recovery (VVITA) Stroke
NCT07103122 · ClinicalTrials.gov ↗ · Stroke
Not applicable Active, closed 2022-03 Italy
Digital Twins for Model-driven Non-invasive Electrical Brain Stimulation
NCT06826261 · ClinicalTrials.gov ↗ · Alzheimer Disease
Not applicable Active, closed 2023-05 Italy
Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome
NCT06620198 · ClinicalTrials.gov ↗ · Guillain Barré Syndrome
Phase 4 Active, closed 2024-10 Italy
Proprioceptive Exercise in Parkinson's Disease
NCT07681609 · ClinicalTrials.gov ↗ · Proprioceptive Training, Physiotherapy
Not applicable Active, closed 2021-05 Italy
Effects of Lokomat Training on Dynamic Postural Stability in Incomplete Spinal Cord Injury
NCT07621900 · ClinicalTrials.gov ↗ · Spinal Cord Injury
Not applicable Active, closed 2026-05 Italy
Design and Validation of Innovative Strategies Based on Dual-Task Approach
NCT07254377 · ClinicalTrials.gov ↗ · Stroke, Multiple Sclerosis, Parkinson Disease
Not applicable Active, closed 2025-11 Italy

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in I.R.C.C.S. Fondazione Santa Lucia trials

15 conditions
Stroke4Alzheimer Disease4Persistent Postural Perceptual Dizziness1Guillain Barré Syndrome1Proprioceptive Training1Physiotherapy1Cerebellar Degeneration1Cerebellar Malformation1Spinal Cord Injury1Stroke, Cardiovascular1Multiple Sclerosis1Parkinson Disease1Dual Task Exercises1Lymphedema, Breast Cancer1Ataxia1
05

Questions about I.R.C.C.S. Fondazione Santa Lucia trials

How many clinical trials does I.R.C.C.S. Fondazione Santa Lucia sponsor?

I.R.C.C.S. Fondazione Santa Lucia is the lead sponsor of 15 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are I.R.C.C.S. Fondazione Santa Lucia trials recruiting?

Yes. 9 of its 15 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.